Oops, you're using an old version of your browser so some of the features on this page may not be displaying properly.

MINIMAL Requirements: Google Chrome 24+, Mozilla Firefox 20+, Internet Explorer 11, Opera 15–18, Apple Safari 7, SeaMonkey 2.15-2.23

Become a member
  1. OncologyPRO
  2. Meeting Resources
  3. ESMO Targeted Anticancer Therapies Congress 2025

New drugs for new targets

Drugs for new synthetic lethality scenarios: WRN and MTAP

Date

05 Mar 2025

Session

New drugs for new targets

Topics

Clinical Research;  Targeted Therapy;  Molecular Oncology

Tumour Site

Oesophageal Cancer;  Melanoma;  Gastric Cancer;  Urothelial Cancer;  Soft Tissue Sarcomas;  Non-Small Cell Lung Cancer;  Mesothelioma;  Hepatobiliary Cancers;  Pancreatic Adenocarcinoma;  Gastro-Oesophageal Junction Cancer

Presenters

Jordi Rodon

Authors

J. Rodon

Author affiliations

  • Drug Development Department, The University of Texas MD Anderson Cancer Center - Main Building, 77030 - Houston/US

Resources

This content is available to ESMO members and event participants.
Login

Resources from the same session

YAP/TEAD inhibitors

Presenter: Anastasios Stathis

Session: New drugs for new targets

Resources:

Slides

Webcast

This site uses cookies. Some of these cookies are essential, while others help us improve your experience by providing insights into how the site is being used.

For more detailed information on the cookies we use, please check our Privacy Policy.

Customise settings

  • Necessary cookies enable core functionality. The website cannot function properly without these cookies, and you can only disable them by changing your browser preferences.